苦参碱注射液对急性病毒性心肌炎的治疗作用

目的:观察苦参碱注射液治疗急性病毒性心肌炎(AVM)的临床疗效.方法:将AVM患者120例随机分为治疗组63例及对照组57例,对照组采用常规疗法,治疗组在对照组基础上给予苦参碱注射液治疗,连用2周.观察临床疗效.结果:治疗组总有效率90.5%,对照组总有效率73.7%,两组比较有显著性差异.治疗组治疗后血清肌酸磷酸激酶(CPK)、天冬氨酸转氨酶(AST)及血清乳酸脱氢酶(LDH)较对照组治疗后明显降低,差异有统计学意义(P＜0.05).结论:苦参碱对急性心肌炎有良好疗效.     

苦参碱注射液对急性病毒性心肌炎的治疗作用

目的：观察苦参碱注射液治疗急性病毒性心肌炎（AVM）的临床疗效。方法：将AVM患者120例随机分为治疗组63例及对照组57例,对照组采用常规疗法,治疗组在对照组基础上给予苦参碱注射液治疗,连用2周。观察临床疗效。结果：治疗组总有效率90.5%,对照组总有效率73.7%,两组比较有显著性差异。治疗组治疗后血清肌酸磷酸激酶（CPK）、天冬氨酸转氨酶（AST）及血清乳酸脱氢酶（LDH）较对照组治疗后明显降低,差异有统计学意义（P〈0.05）。结论：苦参碱对急性心肌炎有良好疗效。     

盐酸多柔比星脂质体注射液与葡萄糖和氯化钠注射液的配伍稳定性研究

目的:研究探讨盐酸多柔星脂质体注射液与葡萄糖和氯化钠注射液配伍的稳定性。方法:将盐酸多柔星脂质体注射液分别和5%的葡萄糖注射液、0.9%氯化钠注射液进行配伍。观察缓和溶液外观、PH值以及脂质体粒径、包封率等相关情况。结果:观察发现,在盐酸多柔星脂质体注射液与0.9%氯化钠注射液配伍后,一定时间内混合溶液的外观、PH值脂质粒径并无明显的变化,但是包封率会下降5%;而盐酸多柔星脂质体注射液与5%葡萄糖住着也配伍后,一定时间内混合溶液的外观、PH值、脂质粒径以及包封率等并无明显的变化。结论:在临床用药中,盐酸多柔星脂质体注射液不应与0.9%氯化钠注射液配伍,与5%葡萄糖注射液配伍具有良好的稳定性,不会对药效的发挥产生影响。     

LC-MS/MS法测定苦参提取物中苦参碱和氧化苦参碱的质量浓度

摘要 目的：探讨液相色谱/串联质谱法(Liquid chromatography-tandem mass spectrometry,LC-MS/MS)测定苦参提取物中苦参碱和氧化苦参碱的质量浓度。方法：验证LC-MS/MS测定苦参提取物中苦参碱、氧化苦参碱的可行性与有效性,并判定检出限、重复性、稳定性、加样回收率。结果绘制苦参碱、氧化苦参碱的检出标准曲线。结果：LC-MS/MS检测苦参提取物中苦参碱与氧化苦参碱的一级质谱图和二级质谱图显示,苦参碱和氧化苦参碱的相对分子量为：248.36、246.36。色谱图显示苦参碱与氧化苦参碱无干扰色谱峰,各成分及内标峰形良好,表明该方法专属性强。在5 μg/L~500 μg/L浓度范围内,苦参碱、氧化苦参碱均呈现良好的线性关系,线性方程分别为y=6.10x-118.29和y=18.29x-14.22,检出限均为0.1 μg/L。LC-MS/MS法测定苦参提取物中苦参碱、氧化苦参碱的重复性、稳定性、加样回收率RSD均<5 %。结论：LC-MS/MS法测定苦参提取物中苦参碱和氧化苦参碱的质量浓度具有可行性、高灵敏度、高特异性等优点,可用于苦参提取物的质量控制与评价,并为后续他人的研究提供关键试验参考条件。     

炎琥宁注射液与6种输液的配伍稳定性考察

目的:研究探讨炎琥宁注射液与6中输液的配伍稳定性。方法:将炎琥宁注射液与5%葡萄糖氯化钠注射液、0.9%氯化钠注射液、复方氯化钠注射液、葡萄糖氯化钠注射液、右旋糖酐40葡萄糖注射液配伍后,观察混合溶液的外观、PH值、炎琥宁注射液的含量以及不溶性微粒的变化。结果:观察实验结果发现,将炎琥宁注射液与6种注射液配伍6h后,混合溶液的PH值、含量并无明显变化,但是在配伍4h后,除去复方氯化钠注射液不溶性微粒符合临床应用规定外,另外的混合液不溶性微粒均不符合使用规定。结论:在临床中,将炎琥宁注射液与其他注射液配伍使用的过程中,应最好与复方氯化钠注射液配伍使用,这样使用符合临床应用标准。     

苦参碱注射液对宫颈癌患者化疗的增敏作用及对T细胞亚群、CA125、IL-6的影响

目的:研究苦参碱注射液对宫颈癌患者化疗的增敏作用及对T细胞亚群、CA125、IL-6的影响。方法:选择2015年4月至2017年3月在我院进行宫颈癌治疗的76例患者,随机将其均分为观察组(59例)和对照组(59例),对照组患者给予化疗,而观察组则在对照组化疗的基础上增加苦参碱注射液进行治疗,记录并比较两组患者治疗前后T细胞亚群、CA125及IL-6水平的变化、肿瘤病灶面积的改善情况、临床疗效及不良反应的发生情况。结果:治疗后,观察组患者的肝肾功能损伤、骨髓抑制剂胃肠道反应等不良反应发生率、血清CA125及IL-6水平均明显低于对照组(P0.05),而总有效率(81.58%)显著高于对照组(50.00%)(P0.05),CD3~+、CD4~+及CD4/CD8~+水平也明显高于对照组(P0.05),而观察组患者CD8~+水平则明显低于对照组(P0.05)。结论:苦参碱注射液辅助宫颈癌化疗的增敏效果显著,能有效降低患者CA125及IL-6水平,显著改善机体T细胞免疫功能。     

苦参碱类生物碱的应用进展

苦参碱是豆科植物苦参、苦豆子、广豆根等中草药的活性成分,是苦参碱类生物碱的代表,这一类生物碱主要还包括氧化苦参碱、槐果碱、氧化槐果碱、槐定碱和槐胺碱等。而对苦参碱和氧化苦参碱的研究最为广泛。苦参碱对中枢神经具有解热、镇痛、抗惊厥、稳定神经等作用;对心血管系统具有明显的负性频率和正性肌力作用、能防治动脉粥样硬化、减轻心肌损伤等作用;对消化系统具有抗肝损伤、抗纤维化、升高白细胞等作用;还具有抗肿瘤、抗肝癌等作用。氧化苦参碱用于治疗白细胞低下和慢性乙型、丙型肝炎、阻止肝纤维化和肝硬化,有抗心律失常、强心、平喘等作用。槐果碱有明显抗柯萨奇B病毒(Coxsackie Virus B,CVB)的作用、免疫调节功能以及抗严重急性呼吸道综合症(Severe Acute Respiratory Syndrome,SARS)病毒的作用。槐定碱有改善心功能、抗炎、抗肿瘤、抗病毒作用。槐胺碱具有免疫抑制、抗心律失常作用。本文综述了这一类生物碱的成分分析及其部分化合物的药理活性和临床应用等方面的研究进展。     

HPLC测定莪术油葡萄糖注射液中四种成分的含量

采用HPLC法测定了莪术油葡萄糖注射液中四种成分(莪术二酮、莪术醇、牻牛儿酮、呋喃二烯)含量。本法以十八烷基硅烷键合硅胶为填充剂,流动相为甲醇-水(85∶15 V/V),流速为0.8mL/min,柱温:30℃,检测波长为215nm。在该色谱条件下,分别建立莪术二酮、莪术醇、牻牛儿酮、呋喃二烯的线性回归方程。结果表明,该法的精密度、重复性、稳定性良好(RSD<2.0%),平均回收率均大于96%(RSD<3.0%,n=5),通过测定得到莪术油葡萄糖注射液中四种主分的含量分别为67,26,20,45μg/mL。HPLC法准确、可靠、重复性良好,可用于莪术油葡萄糖注射液的质量控制。     

HPLC Determination of Four Components in Zedoary Turmeric Oil and Glucose Injection

采用 HPLC 法测定了莪术油葡萄糖注射液中四种成分(莪术二酮、莪术醇、牻牛儿酮、呋喃二烯)含量.本法以十八烷基硅烷键合硅胶为填充剂,流动相为甲醇-水(85:15 V/V),流速为0.8 mL/min,柱温:30℃,检测波长为215 nm.在该色谱条件下,分别建立莪术二酮、莪术醇、牻牛儿酮、呋喃二烯的线性回归方程.结果表明,该法的精密度、重复性、稳定性良好(RSD＜2.0％),平均回收率均大于96 ％(RSD＜ 3.0％,n=5),通过测定得到莪术油葡萄糖注射液中四种主分的含量分别为67,26,20,45 μg/mL.HPLC法准确、可靠、重复性良好,可用于莪术油葡萄糖注射液的质量控制.     

苦参生物碱的研究

从苦参(Sophora flavescens Ait)根中分离得到9个生物碱,用波谱等方法确定为槐果碱(sophocarpine)、苦参碱(matrine)、异苦参碱(isomatrine)、槐醇(sophoranol)、N-甲基野靛碱(N-methylcytisine)、槐定(sophoridine)、氧化苦参碱(oxymatrine)、氧化槐果碱(oxysophocarpine)和氧化槐醇(sophoranol N-oxide)。其中氧化槐醇是首次从苦参根中得到的。     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

The structure, reproduction and taxonomy of Vidalia and Osmundaria (Rhodophyta, Rhodomelaceae)

Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.     

New or rare chromosome counts in Artemisia L. (Asteraceae, Anthemideae) and related genera from Kazakhstan

Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.     

肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细